JUST RELEASED - Transplantation Direct - October 2025 Issue

The October issue of Transplantation Direct is available now for open-access viewing. Several topics are covered in this issue, including quantitative nucleic acid test for BK polyoma virus in kidney transplant recipients; also, biopsy-based transcriptomics variability is compared between kidney transplant centers. In liver transplantation, we feature studies on assessing donor liver quality by testing organ perfusion solution for exosomal small RNA signatures, on how performance status scoring impacts outcomes in obese recipients, on using immune checkpoint inhibitor therapy to downstage hepatocellular carcinoma patients to qualify for transplantation, and on an analysis looking at whether using normothermic machine perfusion can lower costs after DCD transplantation. In addition to these articles, evidence is presented on the use of longitudinal FEV1 measurements as a surrogate for bronchiolitis obliterans evaluation in clinical trials involving lung transplant recipients. On the topic of organ donation, use of DCD donors for simultaneous heart and kidney transplantation is directly compared to using DBD donors. Indeed, we hope that there is something interesting for you in this issue of Transplantation Direct; please visit our open-access website to read all the details.

CLICK HERE TO ACCESS THIS ISSUE


ISN-TTS Program Application Deadline: October 15

The ISN-TTS Sister Transplant Centers Program is a joint partnership set up to create new kidney transplant centers and develop existing kidney transplant programs in emerging economies. Any two transplant centers can form a partnership if at least one center is from a resource-low country (LIC, LMIC, UMIC as per World Bank List of Economies) and the centers are chaired/run by an ISN or a TTS member.

Special ISODP Feature

As part of the on-going collaboration between TTS and our official Sections, and in order to provide TTS members with an update on areas of the field represented by TTS Sections, content for this issue of the Pulse has been submitted by the International Society for Organ Donation Professionals.

The International Society for Organ Donation Professionals (ISODP) is dedicated to advancing the field of organ donation worldwide by leading, developing, and supporting professionals as well as fostering best practices. Over the past year, ISODP has undertaken a range of initiatives in pursuit of this mission, notably preparing for the 17th ISODP Congress, which will take place in Kyoto, Japan, from December 3–6, 2025.

This special ISODP edition of the TTS Tribune features perspectives from a former and a current Councilor, who share insight into current developments in living donation and donor care. They also discuss strategies for expanding education and training in organ donation, an endeavor encapsulated by the ISODP Educational Watch initiative, which curates and disseminates targeted learning opportunities to professionals across the globe.


Altruistic living donors voluntarily donate an organ to save another person’s life, fully aware of the risks of medical complications and potential long-term impacts on their own health. The transplant community bears the responsibility of monitoring and minimizing these risks to safeguard donor well-being.

Living donor transplants offer superior patient and graft survival compared to deceased donor transplantation. The shortage of deceased donors has led to expanded indications for donation known as marginal donors. According to GODT data of 2023, 172,409 solid organ transplants were performed globally, and 31% of these were from living donors(1). The number of living donor transplants for the kidney was 43,101, liver was 10,081, and lung was 10. Considering transplants in WHO regions, living donors contributed 20% in the Americas, 27% in Europe, 32% in the Western Pacific Region, 82% in South-East Asia, 88% in the Eastern Mediterranean region, and 100% in Africa(1).

Given this major contribution, ensuring the health of living donors is essential to sustain and encourage donation. International guidance, including the Amsterdam Forum consensus and KDIGO recommendations, emphasizes the importance of long-term donor follow-up(2). In the United States, UNOS requires transplant centers to follow donors for at least two years(3) and several high-income countries (HICs), including the USA, Canada, the UK, Australia, and New Zealand, have established donor registries to monitor outcomes. Most published reports on donor follow-up originate from HICs. Earlier studies published before 2010 often found no significant long-term consequences of donation. However, more recent research incorporating larger cohorts, longer follow-up (exceeding 10–15 years), and better-matched control groups has shown increased risks of hypertension, cardiovascular disease, end-stage renal disease (ESRD), and mortality(4). Risk of ESRD appears to rise with the donor’s age, duration since donation, and baseline glomerular filtration rate(5).

Data from low-and middle-income countries (LMICs) remain limited. Reports from Sri Lanka and Bangladesh describe increased rates of chronic kidney disease and hypertension even in relatively short follow-up intervals. In Pakistan, a cohort of 2,696 donors followed for up to 27 years demonstrated an incidence of end-stage renal disease in 0.2%, hypertension in 13.7%, and diabetes in 3.6%. When compared with age- and sex-matched non-donors, hypertension, diabetes, and renal function were similar(6).

Despite structured programs, donor follow-up is frequently irregular. Reported non-adherence ranges from 16–20% in the first two years, increasing to 50–60% by years 5–10(7). The main barriers in HICs include logistical and financial constraints, while in LMICs these are compounded by social challenges and lack of infrastructure. Solutions in HICs have included closer integration of transplant centers with primary care providers, as well as use of telemedicine and mobile outreach(8). Some LMIC programs address barriers by offering free follow-up care(9).

Globally, the reliance on living donors continues to grow. These individuals provide not only the “Gift of Life” to recipients but also vital support to transplant systems. Ensuring their long-term health is therefore both an ethical obligation and a public health priority. Regular donor follow-up enables early detection of complications and timely interventions, protecting the well-being of the extraordinary individuals who make transplantation possible.


References
  1. Global Observatory on Donation and Transplantation. International Report on Organ Donation and Transplantation Activities 2023.
    See at: www.transplant-observatory.org/2020-internationctivities-report-%e2%80%8e/Accessed September 18, 2025.
  2. Ethics Committee of the Transplantation Society. The consensus statement of the Amsterdam Forum on the Care of the Live Kidney Donor.
    Transplantation. 2004 Aug 27;78(4):491-2. doi: 10.1097/01.tp.0000136654.85459.1e. PMID: 15446304.
  3. Henderson ML, et al. The National Landscape of Living Kidney Donor Follow-Up in the United States.
    Am J Transplant. 2017 Dec;17(12):3131-3140. doi: 10.1111/ajt.14356. Epub 2017 Jun 30. PMID: 28510355; PMCID: PMC5690895.
  4. Matas AJ, et al. Long-term Medical Outcomes of Living Kidney Donors.
    Mayo Clin Proc. 2022 Nov;97(11):2107-2122. doi: 10.1016/j.mayocp.2022.06.013. Epub 2022 Oct 7. PMID: 36216599; PMCID: PMC9747133.
  5. Wainright JL, et al. Risk of ESRD in prior living kidney donors.
    Am J Transplant. 2018 May;18(5):1129-1139. doi: 10.1111/ajt.14678. Epub 2018 Mar 8. PMID: 29392849.
  6. Rizvi SA, et al. Long-term Safety of Living Kidney Donation in an Emerging Economy.
    Transplantation. 2016 Jun;100(6):1284-93. doi: 10.1097/TP.0000000000001075. PMID: 26854790.
  7. Waterman AD, et al. Living-donor follow-up attitudes and practices in U.S. kidney and liver donor programs.
    Transplantation. 2013 Mar 27;95(6):883-8. doi: 10.1097/TP.0b013e31828279fd. PMID: 23388736.
  8. Thomas AG, et al. Effectiveness of a Mobile Health System on Compliance With 2-Year Living Kidney Donor Follow-Up in the United States.
    Clin Transplant. 2025 Apr;39(4):e70139. doi: 10.1111/ctr.70139.
    Erratum in: Clin Transplant. 2025 Apr;39(4):e70158. doi: 10.1111/ctr.70158. PMID: 40145946; PMCID: PMC12239166.
  9. Zafar MN, et al. Providing "Free" Access to Dialysis and Transplant to the Disfranchised. A Sustainable Model for Low and Low Middle Income Countries (LMICs).
    Transpl Int. 2023 Jul 11;36:11290. doi: 10.3389/ti.2023.11290. PMID: 37497280; PMCID: PMC10367084


The persistent global shortage of organs is compounded by challenges in donation and transplantation systems worldwide. Low-and middle-income countries (LMICs) face particular constraints, including limited infrastructure, fragmented healthcare systems, and a scarcity of structured, affordable training programs. Addressing these barriers requires thoughtful capacity building that prioritizes not only physicians but also policymakers, administrators, and allied health professionals, including nurses, coordinators, and social workers, whose roles are essential to the organ donation pathway. Accessible, scalable training is therefore a cornerstone of sustainable growth in organ donation for transplantation.

In May 2024, the Seventy-Seventh World Health Assembly adopted Resolution WHA77.4, calling on Member States to strengthen workforce capacity(1). The resolution emphasized the importance of robust education strategies and empowering health professionals at all levels. In LMICs, where resources are limited, digital platforms and targeted in-hospital training are critical tools for implementing these recommendations.

Professionalized training programs have demonstrably increased organ donation in various contexts(2–4). The Australian Organ and Tissue Donation and Transplantation Annual Report 2023–24, issued by the Organ and Tissue Authority (OTA), describes initiatives to improve donor identification and family communication through targeted training programs for healthcare professionals(5). The United Arab Emirates (UAE) has similarly demonstrated rapid progress in deceased organ donation. Through the UAE Hayat National Program, capacity building has been institutionalized as a central pillar, integrating donation training into healthcare conferences and certified workshops. In 2023 alone, more than 5,000 professionals across intensive care, neurology, anesthesiology, pediatrics, nursing, and transplant coordination participated(6,7).

Digital platforms offer scalable avenues for LMICs to overcome training barriers. The ISODP Educational Watch (E-W) site, developed by the International Society for Organ Donation Professionals, exemplifies how scientific societies can facilitate healthcare professional education. ISODP E-W consolidates information regarding global available resources, including webinars, lectures, and certified organ donation courses, and provides video examples illustrating key competencies. E-W site guides the users towards the different steps of the organ donation process providing insights regarding the importance of each subject as well as the learning objectives. Through this global directory users can thus select materials appropriate to their needs and local context(8).

Looking forward, the transplantation community must continue to invest in educational equity. Partnerships among international societies, national programs, and academic institutions are essential to expand access, adapt curricula to local contexts, and evaluate outcomes. Training should remain sensitive to cultural, infrastructural, and epidemiological realities while promoting adherence to international best practices. Strengthening the role of allied health professionals through accessible training represents one of the most effective strategies to expand donation capacity in LMICs and reduce the global burden of organ failure.

In conclusion, capacity building in organ donation requires accessible, multidisciplinary training tailored to LMIC realities. The ISODP Educational Watch site illustrates the potential of collaborative, innovative educational initiatives. By implementing the WHO resolution’s recommendations through practical, scalable programs, the global transplantation community can advance equitable access to life-saving transplantation.


References
  1. World Health Organization. Increasing availability, ethical access and oversight of transplantation of human cells, tissues and organs. WHA77.4. Geneva, Switzerland: WHO; 2024.
  2. Gardiner D, et al. NHS Blood and Transplant annual report.
    Br J Anaesth. 2012;108(suppl 1):i56–i67.
  3. Peralta P, et al; EUDONORGAN Consortium. "Train the Trainers" program to improve knowledge, attitudes and perceptions about organ donation in the European Union and neighbouring countries: pre- and post-data analysis of the EUDONORGAN project.
    Transpl Int. 2023;36(4):373–384. doi:10.1111/tri.13684.
  4. Potter J, et al. Simulation-based communication skills training for deceased organ donation: a randomized controlled trial.
    J Pain Symptom Manage. 2017;54(5):734–741. doi:10.1016/j.jpainsymman.2017.06.009.
  5. Organ and Tissue Authority. Australian Organ and Tissue Donation and Transplantation Annual Report 2023–24. Canberra, Australia: OTA; 2023.
    Available at: www.donatelife.gov.au/sites/default/files/2024-10/OTA%20Annual%20Report%202023-24.pdf Accessed September 14, 2025.
  6. Gómez MP, et al. Deceased organ donation and transplantation in the United Arab Emirates: a view 7 y after implementation.
    Transplantation. 2025;109(7):1055–1058. doi:10.1097/TP.0000000000005358.
  7. Gómez MP, et al. Utilizing healthcare conferences to promote awareness and knowledge of organ donation and transplantation in UAE.
    Transplantation. 2024;108(9S):S.
  8. International Society for Organ Donation and Procurement (ISODP). ISODP Educational Watch.
    Available at: www.tts.org/isodp-education/isodp-educational-watch-current Accessed September 14, 2025.


ISODP Congress 2025
Kyoto Japan 3-6 December 2025

We are excited that the next ISODP Congress will take place in Kyoto, Japan, from December 3 to 6, 2025. The congress will focus on the latest advancements in donation and transplantation practices, including donation after circulatory determination of death, machine perfusion techniques, optimizing donation and organ utilization, and much more.

In collaboration with our esteemed Japanese colleagues and hosts, we have curated an exceptional program that promises to enhance your knowledge and networking opportunities.


Annual Conference of the Indian Society of Organ Transplantation - October 9-12

The Indian Society of Transplantation (ISOT) 2025 conference promises to be an extraordinary gathering, bringing together distinguished experts, pioneering researchers, and industry leaders from across the globe. Over the course of four days, we will present a comprehensive scientific program, thought-provoking keynote addresses, engaging panel discussions, and hands-on workshops. This conference aims to serve as a dynamic platform for sharing cutting-edge advancements, presenting ground-breaking research, and delving into the latest trends and innovations in the realm of organ transplantation.

We warmly invite all delegates to visit our Executive Director, Marcelle McPhaden at The Transplantation Society (TTS) booth and meet up with the many TTS leaders who will be present. Learn more about TTS, our many initiatives and projects as well as educational and networking opportunities. We look forward to connecting with you at ISOT 2025.


Honoring and Celebrating 50 Years of Organ Transplantation in Türkiye


Ethics and Challenges Involving Uterus Transplantation - Manuscript Published

Stefan G. Tullius, United States
ISUTx Vice President
Harvard University
Brigham & Women’s Hospital, Boston, MA, USA
Anji Wall, United States
Baylor Simmons Transplant Institute
Fort Worth, TX, USA

Clinical uterus transplantation represents a wonderful success story, now more than 10 years after its successful implementation. Today uterus transplantation is an established clinical procedure, with programs around the world. With clinical advancements, new ethical challenges have evolved, and a group put together by the International Society of Uterus Transplantation (ISUTx) has attempted to answer questions about how and if to include new populations, starting new programs, and transitioned from research into clinical practice.

All those aspects are carefully debated in this very thoughtful manuscript titled Evolving ethical challenges after a decade of uterus transplantation and recommendations from the International Society of Uterus Transplantation Ethics Committee by Anji Wall with co-workers from the ISUTx. An essential read to move uterus transplantation forward in an ethical way. Please read this manuscript, attached below.


Transplantation Journal Highlights

Transplantation Journal - Social Media Content

G-LERP/miR-374i-b Attenuates IRI and Suppresses Hepatocellular Carcinoma Progression
Liver transplantation (LT) is the most effective therapeutic strategy for late-stage hepatocellular carcinoma (HCC), but it is prone to ischemia–reperfusion injury (IRI), leading to poor prognosis. Previous articles have reported that miR-374b-5p expression is increased in HCC tissues, and its relationship with IRI and HCC carcinoma progression is unclear.
Patient Selection for Xenotransplant Human Clinical Trials: A Data-driven Approach
The organ shortage remains the greatest unmet need in transplantation. Only 4% of the patients with organ failure will receive a transplant annually. Many of the remaining patients will either get too sick to benefit from a transplant or die waiting. Identifying an alternative source of organs will be essential to addressing this recalcitrant problem. Recent progress in xenotransplantation, which involves using genetically modified pig organs, offers a promising solution and sets the stage for human clinical trials to begin.

Transplantation Direct - Social Media Content

Extracorporeal Photopheresis: Does It Have a Potential Place Among Cell-based Therapies?
Extracorporeal photopheresis (ECP) is a therapeutic intervention for modulating immune responses using an autologous apoptotic cell-based product, known as a photopheresate. The process of generating photopheresates offers attractive possibilities for manipulating distinct leukocyte subsets to either augment or dampen immune responses, depending on the disease context. This review discusses current uses of ECP as a cell-based therapy and introduces possible strategies to enhance the potency of photopheresates.
Sex Differences in Excess Mortality Among Waitlisted Kidney, Heart, and Liver Transplant Candidates
Sex differences in excess mortality risk (ie, above expected in the age-, sex-, and race-matched general population) among candidates waitlisted for transplant may reflect sex bias in access to the waitlist, disparities in allocation policies, and/or sex differences in care for patients with organ failure.

2025 Advancing Diversity, Equity & Inclusion in Transplantation Conference - October 25-26

It is our great pleasure to invite you to attend the 2025 Advancing Diversity, Equity & Inclusion in Transplantation: A Global Perspective Conference, taking place October 25 - 26, 2025 in Toronto, Ontario. This second edition will be co-located with the 6th Congress of International Advanced HBP Surgery (ISLS 2025).

Students, Trainees, Allied Health Professional, and Community members or patients save with special rates and hotel discount. DEI in Transplant registrants also receive a 15% discount for ISLS 2025.

Follow #DEIinTransplant2025 on social media:
x.com/DEIinTransplant
www.linkedin.com/company/deiintransplant

2025 Donate Life Egypt Congress - November 12-15

Join us for the International Transplant Congress of Donate Life Egypt (DLE 2025) and be part of one of the leading global meetings in transplantation!

Donate Life Egypt (DLE) represents all professionals involved in transplantation in Egypt. It includes surgeons, hepatologists, nephrologists, anesthetists, pediatricians, radiologists, pathologists, specialists in infectious diseases, pharmacists, nutritionists, transplant coordinators and nurses. DLE is the professional voice of organ transplantation in Egypt providing leadership, representation, and guidance for the benefit of our patients.


Asian Transplantation Week 2025 (ATW 2025) - November 20-22

Since its international expansion in 2016, ATW has continued to evolve as a leading platform for transplantation professionals across the Asia-Pacific region. Each year, the congress has seen remarkable growth both in scale and in the quality of its scientific content.

This year, under the theme “Together for Innovation: Breaking Boundaries in Asian Transplantation” ATW 2025 is set to offer a dynamic and forward-looking scientific program. It will bring together global experts to share emerging insights, debate pressing challenges, and foster meaningful dialogue across diverse areas of transplantation.


In the News


Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada